More than 20 Spanish hospitals collaborate with Mikrobiomik in the clinical development of the first biological drug based on gut microbiota

Breaking News, NewsLeave a comment

The Bizkaia-based company has launched its phase III clinical trial with the aim of becoming the first company in the world to market the first biological drug based on intestinal microbiota, in the indication of recurrence due to Clostridioides difficile (ICD). The biopharmaceutical company, based at the BIC Bizkaia bioincubator, is also supplying its investigational…